Basic Information
Basic information for C21orf62-AS1-203-49aa
Peptide Name C21orf62-AS1-203-49aa
Genome Position chr21:32799283-32799429[+]
Species Human
Peptide Sequence MPSKSADICLTLWDIFRFSNWLLYWRAPRFYHPRIFKDFCRDTLWVLHL
Peptide Length 49
Unique Yes
Grand Average of Hydropathicity -0.0041
Relative Molecular Mass 7040.97
Experimental Evidences no
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000382378;C21orf62-AS1-203
Transcript Length 3352
Coding Ability 0.4538
DNA Sequence Corresponding to Peptide ATGCCCTCTAAGAGTGCAGATATATGTCTGACTTTGTGGGATATATTCAGATTTTCAAATTGGCTCCTTTACTGGAGGGCCCCTCGATTTTACCACCCAAGAATCTTCAAGGATTTTTGCAGGGACACACTTTGGGTACTGCATTTG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :